Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Todos Med (CE) (TOMDF)

Todos Med Ltd (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:TOMDF
DateTimeSourceHeadlineSymbolCompany
17/07/202313:29Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:TOMDFTodos Med Ltd (CE)
16/05/202320:07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:TOMDFTodos Med Ltd (CE)
31/03/202321:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
31/03/202321:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:TOMDFTodos Med Ltd (CE)
29/03/202319:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TOMDFTodos Med Ltd (CE)
15/03/202314:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:TOMDFTodos Med Ltd (CE)
13/09/202221:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
13/09/202211:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:TOMDFTodos Med Ltd (CE)
01/09/202214:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
24/08/202217:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TOMDFTodos Med Ltd (CE)
22/08/202221:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TOMDFTodos Med Ltd (CE)
22/08/202221:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:TOMDFTodos Med Ltd (CE)
15/08/202221:33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:TOMDFTodos Med Ltd (CE)
12/08/202221:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:TOMDFTodos Med Ltd (CE)
10/08/202221:41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
05/08/202221:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
03/08/202214:48InvestorsHub NewsWireTodos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista DiagnosticsUSOTC:TOMDFTodos Med Ltd (CE)
16/05/202222:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:TOMDFTodos Med Ltd (CE)
06/04/202220:59Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TOMDFTodos Med Ltd (CE)
31/03/202223:17Edgar (US Regulatory)Annual Report (10-k)USOTC:TOMDFTodos Med Ltd (CE)
17/03/202210:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
07/02/202211:04Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:TOMDFTodos Med Ltd (CE)
27/01/202213:30InvestorsHub NewsWireTodos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 PatientsUSOTC:TOMDFTodos Med Ltd (CE)
18/01/202221:04Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:TOMDFTodos Med Ltd (CE)
02/12/202115:39InvestorsHub NewsWireSA Breaking News - PURA expects to sign first contracts this monthUSOTC:TOMDFTodos Med Ltd (CE)
29/11/202121:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
16/11/202111:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
22/10/202120:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
27/09/202111:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
24/09/202114:59Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TOMDFTodos Med Ltd (CE)
 Showing the most relevant articles for your search:USOTC:TOMDF